Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Endocrine 2Thoracic 1Sarcoma 1NET 1Gynecologic 1CNS 1

Conditions

Neuroblastoma 5Colonic Neoplasms 5Pancreatic Neoplasms 3Osteosarcoma 3Melanoma 3Medulloblastoma 3Glioblastoma 3Familial ependymoma 3Stomach Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Optic Nerve Glioma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasms 2Neoplasm Metastasis 2Nasopharyngeal Neoplasms 2Multiple Myeloma 2Gallbladder Neoplasms 2Colorectal Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Astrocytoma 2Wilms Tumor 1Vipoma 1Thyroid Neoplasms 1Testicular Neoplasms 1Teratoma 1Squamous Cell Carcinoma of Head and Neck 1Somatostatinoma 1

Interventions

tipifarnib 1temsirolimus 1pentetreotide 1Vinorelbine 1Trastuzumab 1Sirolimus 1Oxaliplatin 1Leucovorin 1Floxuridine 1Fentanyl 190Y-octreotide, DOTA-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Islet Cell × Oxaliplatin × CNS × Clear all
NCT00005860 2011-04-26

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

National Cancer Institute (NCI)

Phase 1 Completed
CNSEndocrineGastrointestinalGynecologicSarcoma

Appendiceal Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Vipoma, Fallopian Tube Neoplasms, Gallbladder Neoplasms, Glucagonoma, Carcinoma, Hepatocellular, Insulinoma, Neoplasms, Neoplasms, Unknown Primary, Neuroblastoma, Pancreatic Neoplasms, Pheochromocytoma, Pseudomyxoma Peritonei, Somatostatinoma, Stomach Neoplasms, Gastrinoma, Carcinoma, Islet Cell, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡